Intraocular Silicone Implant to Treat Chronic Ocular Hypotony-preliminary Feasibility Data

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2016 May 12

PMID 27165132

Citations 3

Authors

Wesal Bayoudh

Markus Frentz

Dorthe Carstesen

Barbara Dittrich

Caroline Reismann

Norbert F Schrage

Peter Walter

Andreas W A Weinberger

Affiliations

Soon will be listed here.

Abstract

Purpose: Ocular hypotony secondary to proliferative vitreoretinopathy-related retinal detachment, trauma or inflammation is difficult to treat. Besides endotamponades such as silicone oil, vitreous implants such as iris diaphragms or balloons have been developed to stabilize the eye and to prevent phthisis of the globe. Vitreous implants tested thus far exhibit a seam at the attachment site of the hemispheres, or micropores. This manuscript reports the development of a seamless silicone balloon implant without micropores, which can be filled with silicone oil and surface-modified to improve its biocompatibility. Developed for intraocular placement in the management of chronic hypotony and phthisis prevention, it may also be suitable for tamponading retinal detachments.

Methods: Silicone was used as the basic structure for the fabrication of a seamless balloon-shaped intraocular implant, which was coated by employing a six-arm star-shaped (sP) macromer of a copolymer of 80 % ethylene oxide (EO) and 20 % propylene oxide (PO) with conjugated functional terminal isocyanate groups, NCO-sP(EO-stat-PO), with and without heparin. Three variants of implants, which differ in their surfaces, were manufactured: uncoated silicone, NCO-sP (EO-stat-PO) coated silicone and heparin-NCO-sP (EO-stat-PO) coated silicone implants. To exert a tamponade effect, the implant was filled with silicone oil and its properties were studied.

Results: Seamless thin balloon implants made of silicone, which are considered biocompatible and intrinsically resistant to biological attacks in vivo, could be fabricated in different sizes. The silicone oil-filled implant can mimic the mechanism of buoyant force and high surface tension of silicone oil, which is the only long-term vitreous substitute currently available. The silicone oil-filled implant can also mimic the natural vitreous body by occupying the entire posterior segment.

Conclusions: The intraocular silicone implant as an alternative long-term treatment of chronic ocular hypotony might offer a new option for clinical ophthalmological practice. In vivo studies need to be performed to collect more data on the implant's long-term mechanical and optical properties, as well as long-term biocompatibility.

Citing Articles

Development and material characteristics of glaucoma surgical implants.

Qin Q, Zhang C, Yu N, Jia F, Liu X, Zhang Q Adv Ophthalmol Pract Res. 2023; 3(4):171-179.

PMID: 38106549 PMC: 10724012. DOI: 10.1016/j.aopr.2023.09.001.

The Role of Soft Robotic Micromachines in the Future of Medical Devices and Personalized Medicine.

Garcia L, Kerns G, OReilley K, Okesanjo O, Lozano J, Narendran J Micromachines (Basel). 2022; 13(1).

PMID: 35056193 PMC: 8781893. DOI: 10.3390/mi13010028.

Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial.

Bayoudh W, Carstesen D, Walter P, Weinberger A Graefes Arch Clin Exp Ophthalmol. 2017; 255(10):1947-1955.

PMID: 28674834 DOI: 10.1007/s00417-017-3714-x.

References

Rachal W, Burton T . Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol. 1979; 97(3):480-3. DOI: 10.1001/archopht.1979.01020010230008. View

Jonas J, Vossmerbaeumer U, Kamppeter B . Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand. 2004; 82(5):637. DOI: 10.1111/j.1600-0420.2004.00319.x. View

Couvillion G, Freeman H, Schepens C . Vitreous surgery. 3. Intraocular balloon: instrument report. Arch Ophthalmol. 1970; 83(6):713-4. DOI: 10.1001/archopht.1970.00990030713007. View

Groll J, Ameringer T, Spatz J, Moeller M . Ultrathin coatings from isocyanate-terminated star PEG prepolymers: layer formation and characterization. Langmuir. 2005; 21(5):1991-9. DOI: 10.1021/la047439f. View

Cohen Tervaert J, Kappel R . Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld's syndrome). Immunol Res. 2013; 56(2-3):293-8. DOI: 10.1007/s12026-013-8401-3. View

Fischer S, Carstesen D, Klee D, Walter P, Weinberger A . Surface-modified silicone foils for intraocular implantation. Graefes Arch Clin Exp Ophthalmol. 2012; 250(6):823-7. DOI: 10.1007/s00417-012-1956-1. View

Pivetti-Pezzi P, Da Dalt S, La Cava M, Pinca M, De Gregorio F, VIRNO M . Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report. Eur J Ophthalmol. 2001; 10(4):332-4. DOI: 10.1177/112067210001000411. View

Kapur R, Birnbaum A, Goldstein D, Tessler H, Shapiro M, Ulanski L . Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina. 2009; 30(1):140-5. PMC: 3695593. DOI: 10.1097/IAE.0b013e3181b32f06. View

Schramm C, Spitzer M, Henke-Fahle S, Steinmetz G, Januschowski K, Heiduschka P . The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute. Invest Ophthalmol Vis Sci. 2011; 53(2):613-21. DOI: 10.1167/iovs.11-7322. View

10.

Janowsky E, Kupper L, Hulka B . Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000; 342(11):781-90. DOI: 10.1056/NEJM200003163421105. View

11.

OConnell S, Majji A, Humayun M, de Juan Jr E . The surgical management of hypotony. Ophthalmology. 2000; 107(2):318-23. DOI: 10.1016/s0161-6420(99)00047-0. View

12.

Satulovsky J, Carignano M, Szleifer I . Kinetic and thermodynamic control of protein adsorption. Proc Natl Acad Sci U S A. 2000; 97(16):9037-41. PMC: 16817. DOI: 10.1073/pnas.150236197. View

13.

Heyes C, Groll J, Moller M, Nienhaus G . Synthesis, patterning and applications of star-shaped poly(ethylene glycol) biofunctionalized surfaces. Mol Biosyst. 2007; 3(6):419-30. DOI: 10.1039/b700055n. View

14.

Tosi G, Schiff W, Barile G, Yoshida N, Chang S . Management of severe hypotony with intravitreal injection of viscoelastic. Am J Ophthalmol. 2005; 140(5):952-4. DOI: 10.1016/j.ajo.2005.06.019. View

15.

Hauser J, Esenwein S, Awakowicz P, Steinau H, Koller M, Halfmann H . Sterilization of heat-sensitive silicone implant material by low-pressure gas plasma. Biomed Instrum Technol. 2011; 45(1):75-9. DOI: 10.2345/0899-8205-45.1.75. View

16.

Maruoka S, Matsuura T, Kawasaki K, Okamoto M, Yoshiaki H, Kodama M . Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 2006; 31(7-8):599-606. DOI: 10.1080/02713680600813854. View

17.

Gnad H, Paroussis P, Skorpik C . An intraocular balloon for silicone oil implantation. Graefes Arch Clin Exp Ophthalmol. 1986; 224(1):18-20. DOI: 10.1007/BF02144126. View

18.

Fernando Arevalo J, Garcia R, Fernandez C . Anterior segment inflammation and hypotony after posterior segment surgery. Ophthalmol Clin North Am. 2004; 17(4):527-37, vi. DOI: 10.1016/j.ohc.2004.06.004. View

19.

Kreissig I, Failer J, Lincoff H, Ferrari F . Results of a temporary balloon buckle in the treatment of 500 retinal detachments and a comparison with pneumatic retinopexy. Am J Ophthalmol. 1989; 107(4):381-9. DOI: 10.1016/0002-9394(89)90661-2. View

20.

Morse L, McCuen 2nd B . The use of silicone oil in uveitis and hypotony. Retina. 1991; 11(4):399-404. DOI: 10.1097/00006982-199111040-00006. View